Cardiac sympathetic innervation and mortality risk scores in patients with heart failure
暂无分享,去创建一个
P. Gargiulo | G. Corbi | N. Ferrara | A. Cuocolo | G. Rengo | R. Assante | P. Perrone Filardi | K. Komici | S. Paolillo | C. Nappi | G. Gambino | L. Bencivenga | G. D. Femminella | Fabio Santillo
[1] P. Gargiulo,et al. 123I-MIBG imaging in heart failure: impact of comorbidities on cardiac sympathetic innervation , 2022, European Journal of Nuclear Medicine and Molecular Imaging.
[2] M. Petretta,et al. Simultaneous assessment of myocardial perfusion and adrenergic innervation in patients with heart failure by low-dose dual-isotope CZT SPECT imaging , 2022, Journal of Nuclear Cardiology.
[3] G. Sinagra,et al. [ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: what's new?] , 2022, Giornale italiano di cardiologia.
[4] A. Curnis,et al. One-year mortality after implantable defibrillator implantation: do risk stratification models help improving clinical practice? , 2021, Journal of Interventional Cardiac Electrophysiology.
[5] Natasha Meunier-McVey,et al. 2021 ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure , 2021, EMJ Cardiology.
[6] J. McMurray,et al. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. , 2021, European heart journal.
[7] G. Rengo,et al. Why Do We Not Assess Sympathetic Nervous System Activity in Heart Failure Management: Might GRK2 Serve as a New Biomarker? , 2021, Cells.
[8] P. Filardi,et al. Impact of the number of comorbidities on cardiac sympathetic derangement in patients with reduced ejection fraction heart failure. , 2021, European journal of internal medicine.
[9] W. Zareba,et al. Predicted benefit of an implantable cardioverter-defibrillator: the MADIT-ICD benefit score. , 2021, European heart journal.
[10] T. Nakata,et al. Machine learning-based risk model using 123I-metaiodobenzylguanidine to differentially predict modes of cardiac death in heart failure , 2020, Journal of Nuclear Cardiology.
[11] P. Filardi,et al. Impact of body mass index on cardiac adrenergic derangement in heart failure patients: a 123I-mIBG imaging study , 2019, European Journal of Nuclear Medicine and Molecular Imaging.
[12] D. Leosco,et al. β-Adrenergic Receptor Signaling and Heart Failure: From Bench to Bedside. , 2019, Heart failure clinics.
[13] S. Rosenheck,et al. Developing a risk score to predict mortality in the first year after implantable cardioverter defibrillator implantation: Data from the Israeli ICD Registry , 2018, Journal of cardiovascular electrophysiology.
[14] R. L. Carter,et al. Denervated Myocardium Is Preferentially Associated With Sudden Cardiac Arrest in Ischemic Cardiomyopathy: A Pilot Competing Risks Analysis of Cause-Specific Mortality , 2017, Circulation. Cardiovascular imaging.
[15] N. Ferrara,et al. Management and Treatment of Cardiovascular Diseases in the Elderly , 2017 .
[16] M. Rosenqvist,et al. Clinical risk profile score predicts all cause mortality but not implantable cardioverter defibrillator intervention rate in a large unselected cohort of patients with congestive heart failure , 2017, Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc.
[17] Gerasimos S Filippatos,et al. 2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America. , 2017, Journal of cardiac failure.
[18] G. Fonarow,et al. 2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America. , 2017, Circulation.
[19] M. Henzlova,et al. Assessment of 123I-mIBG and 99mTc-tetrofosmin single-photon emission computed tomographic images for the prediction of arrhythmic events in patients with ischemic heart failure: Intermediate severity innervation defects are associated with higher arrhythmic risk , 2017, Journal of Nuclear Cardiology.
[20] H. Verberne,et al. Cardiac sympathetic activity in chronic heart failure: cardiac 123I-mIBG scintigraphy to improve patient selection for ICD implantation , 2016, Netherlands Heart Journal.
[21] P. Gargiulo,et al. Sleep-disordered breathing, impaired cardiac adrenergic innervation and prognosis in heart failure , 2016, Heart.
[22] W. Levy,et al. Cost-Effectiveness Analysis of Iodine-123 Meta-Iodobenzylguanidine Imaging for Screening Heart Failure Patients Eligible for an Implantable Cardioverter Defibrillator in the USA , 2016, Applied Health Economics and Health Policy.
[23] M. Cerqueira,et al. A selection of recent, original research papers , 2015, Journal of Nuclear Cardiology.
[24] D. Leosco,et al. Impact of Diabetes on Cardiac Sympathetic Innervation in Patients With Heart Failure , 2013, Diabetes Care.
[25] M. Petretta,et al. Observer reproducibility of results from a low-dose 123I-metaiodobenzylguanidine cardiac imaging protocol in patients with heart failure , 2013, European Journal of Nuclear Medicine and Molecular Imaging.
[26] G. Stukenborg,et al. Prediction of mortality in clinical practice for medicare patients undergoing defibrillator implantation for primary prevention of sudden cardiac death. , 2012, Journal of the American College of Cardiology.
[27] Roxy Senior,et al. Selective improvement in Seattle Heart Failure Model risk stratification using iodine-123 meta-iodobenzylguanidine imaging , 2012, Journal of Nuclear Cardiology.
[28] Jeroen J. Bax,et al. Clinical prediction model for death prior to appropriate therapy in primary prevention implantable cardioverter defibrillator patients with ischaemic heart disease: the FADES risk score , 2012, Heart.
[29] D. Hodge,et al. Development and validation of a risk score to predict early mortality in recipients of implantable cardioverter-defibrillators. , 2012, Heart rhythm.
[30] L. Jordaens,et al. The prognosis of implantable defibrillator patients treated with cardiac resynchronization therapy: comorbidity burden as predictor of mortality , 2010, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.
[31] D. Le Guludec,et al. Proposal for standardization of 123I-metaiodobenzylguanidine (MIBG) cardiac sympathetic imaging by the EANM Cardiovascular Committee and the European Council of Nuclear Cardiology , 2010, European Journal of Nuclear Medicine and Molecular Imaging.
[32] M. Cerqueira,et al. Myocardial iodine-123 meta-iodobenzylguanidine imaging and cardiac events in heart failure. Results of the prospective ADMIRE-HF (AdreView Myocardial Imaging for Risk Evaluation in Heart Failure) study. , 2010, Journal of the American College of Cardiology.
[33] D. Moher,et al. A catalogue of reporting guidelines for health research , 2010, European journal of clinical investigation.
[34] Javed Butler,et al. The sympathetic nervous system in heart failure physiology, pathophysiology, and clinical implications. , 2009, Journal of the American College of Cardiology.
[35] A. Moss,et al. Risk stratification for primary implantation of a cardioverter-defibrillator in patients with ischemic left ventricular dysfunction. , 2008, Journal of the American College of Cardiology.
[36] W. Stevenson,et al. Predicting early mortality after implantable defibrillator implantation: a clinical risk score for optimal patient selection. , 2006, American heart journal.
[37] J. Oss,et al. PROPHYLACTIC IMPLANTATION OF A DEFIBRILLATOR IN PATIENTS WITH MYOCARDIAL INFARCTION AND REDUCED EJECTION FRACTION , 2002 .
[38] A. Hishida,et al. Cardiac Autonomic Neuropathy in Patients with Chronic Renal Failure on Hemodialysis , 2000, Nephron.
[39] G. Jennings,et al. Adrenergic nervous system in heart failure. , 1997, The American journal of cardiology.
[40] J A Swets,et al. Measuring the accuracy of diagnostic systems. , 1988, Science.